Option Systems Antibacterial Foaming Hand Wash with .3% PCMX, 1000 mL pouches, Inopak, LTD, Ringw...

FDA Drug Recall #D-0864-2018 — Class II — May 16, 2018

Recall Summary

Recall Number D-0864-2018
Classification Class II — Moderate risk
Date Initiated May 16, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Inopak Ltd
Location Ringwood, NJ
Product Type Drugs
Quantity 1345 cases

Product Description

Option Systems Antibacterial Foaming Hand Wash with .3% PCMX, 1000 mL pouches, Inopak, LTD, Ringwood, NJ

Reason for Recall

Microbial contamination of NonSterile Product; FDA analysis returned out of specification results for total aerobic microbial counts

Distribution Pattern

Nationwide

Lot / Code Information

7302 01 039, 7302 03 039, 7302 01 040 and 7302 01 043

Other Recalls from Inopak Ltd

Recall # Classification Product Date
D-1312-2019 Class II Instant Waterless Hand Sanitizer, Ethyl Alcohol... Apr 22, 2019
D-1313-2019 Class II INODERM Antiseptic Hand Soap (E-2), .6% (incorr... Apr 22, 2019
D-1315-2019 Class II Antibacterial Hand Soap, Healthcare 2000, label... Apr 22, 2019
D-1314-2019 Class II INOFOAM Foaming E-2 Food Handling Wash with .6%... Apr 22, 2019
D-1317-2019 Class II Sani-Guard-SF Waterless Foam Hand Sanitizer, Et... Apr 22, 2019

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.